Imunon schedules Q2 results, business update conference call

• Imunon scheduled a conference call at 11 a.m. EDT on Aug. 11, 2026 to report Q2 2026 results.
• Call also set to provide an update on Phase 3 development of IMNN-001 in newly diagnosed advanced ovarian cancer.
• Live webcast available at this link.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imunon Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608040800PRIMZONEFULLFEED9801795) on August 04, 2026, and is solely responsible for the information contained therein.